Sana Biotechnology, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
SANA Nasdaq 2836 www.sana.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sana Biotechnology, Inc.

Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum - Jan 8th, 2026 12:13 pm
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference - Jan 7th, 2026 2:26 pm
Three Genomics Stocks Worth Tracking This Year - Jan 6th, 2026 5:06 am
Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication - Dec 28th, 2025 8:05 am
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform - Dec 8th, 2025 7:00 am
Will Sana Biotechnology’s (SANA) Pipeline Focus Reveal Strategic Priorities in Diabetes and Autoimmune Innovation? - Dec 1st, 2025 12:05 am
Sana Biotechnology (SANA): Assessing Valuation After Strong Year-to-Date Share Price Gains - Nov 30th, 2025 8:07 am
Sana (SANA) Surges 14.5% Ahead of Business Announcements - Nov 28th, 2025 8:11 am
Sana Biotechnology to Present at December 2025 Investor Conferences - Nov 24th, 2025 2:05 pm
Top 3 Genomics Stocks to Consider for Your Portfolio - Nov 18th, 2025 6:48 am
Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength - Nov 18th, 2025 4:17 am
Can Sana Biotechnology’s (SANA) Leaner Cost Structure Strengthen Its Long-Term Competitive Position? - Nov 16th, 2025 5:13 pm
All You Need to Know About Sana (SANA) Rating Upgrade to Buy - Nov 12th, 2025 10:00 am
Assessing Sana Biotechnology’s (SANA) Valuation After Strategic Refocus and Encouraging Clinical Updates - Nov 9th, 2025 12:06 am
Sana: Q3 Earnings Snapshot - Nov 6th, 2025 2:26 pm
Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates - Nov 6th, 2025 2:05 pm
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit - Nov 4th, 2025 2:05 pm
Progressive stock sinks on Q3 miss, gold hits yet another record - Oct 15th, 2025 10:07 am
Sana Biotechnology stock higher after Eric Jackson touts 100-bagger potential - Oct 15th, 2025 8:45 am
Sana Biotechnology (SANA): Evaluating Valuation Following Recent 47% Share Price Surge - Oct 9th, 2025 9:12 pm